Transmembrane formulations for drug administration

Details Transmembrane formulations for drug administration Transmembrane formulations for drug administration

1989-01-19

1991-02-19

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424 45, 514 2, 514171, 514808, 514922, 514947, 514958, 514975, A61K 908, A61K 910, A61K 912, A61K 3702

Patent

active

049944398

ABSTRACT:
Compositions for the administration of protein or peptide drugs across membranes show low toxicity and efficient permeation when the medium is a mixture of a bile salt or fusidate with a nonionic detergent. Various specific compositions are exemplified.

REFERENCES:
patent: 3230240 (1966-01-01), Godtfredsen et al.
patent: 3867413 (1975-02-01), Daehne et al.
patent: 3920817 (1975-11-01), Godtfredsen
patent: 4100276 (1978-07-01), von Daehne et al.
patent: 4119717 (1978-10-01), von Daehne et al.
patent: 4153689 (1979-05-01), Hirai et al.
patent: 4323558 (1982-04-01), Nelson
patent: 4372888 (1983-02-01), Hjelmeland
patent: 4537776 (1985-08-01), Cooper
patent: 4548922 (1985-10-01), Carey et al.
patent: 4557934 (1985-10-01), Cooper
patent: 4746508 (1988-05-01), Carey et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4789660 (1988-12-01), Enever et al.
Longenecker et al., C.A. 107: 83791k (1987).
Duchateau et al. C.A. 107: 242511n (1987).
Su et al. C.A. 106: 162571w (1986) of EP 200383, Dec. 10, 1986.
Veda et al. C. G. 104: 10621h (1986) of JP 60/16192y, Aug. 23, 1985.
Martin et al. C. A. 110: 121402f (1989) of PCT WO88/01864, Mar. 24, 1988.
G. S. M. J. E. Duchateu et al., Int. J. Pharm. 39: 87-92 (1987).
J. P. Longenecker et al., J. Pharm. Sci.: 351-355 (1987).
W. A. Lee et al., "Intranasal Bioavailability of Insulin Powder Formulations . . ." submitted to J. Pharm. Sci., in press.
R. D. Ennis et al., Pharm. Res. 7 (5): 468-475 (1990).
Carey et al., Biochem. (1975) 22(14): 4896-4904.
Carey et al., J. Lipid Res. (1971) 12: 605-613.
Carey et al., "Bile Acids In Gastroenterology" (1983), pp. 19-56.
Deuxchaisnes et al., "Effect of a Nasal Spray of Slamon Calcitonin in Normal Subjects and in Patients with Paget's Disease of Bone", Elsevier Science Publishers BV, A. Pecile, Editor, pp. 329-343.
Deuxchaisnes et al., British Med J. (1985) 291: 544-545.
Gordon et al., Proc. Natl. Acad. Sci. (1985) 82: 7419-7423.
Hjelmeland et al., Analytical Biochem. (1983) 130: 72-82.
Kiebzak et al., Gen. and Compar. Endocrinol. (1982) 48: 232-238.
Morimoto et al., J. Pharmaceutical Sci. (1984) 72(10): 1366-1368.
Muranishi, Meth. and Find. Exptl. Clin. Pharmacol. (1984) 6(12):763-772.
Ziegler et al., Acta Endocrin. Suppl. (1978) 215: 54-55.

Affiliated with

Also associated with

Rating

Transmembrane formulations for drug administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transmembrane formulations for drug administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transmembrane formulations for drug administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1143661